Cargando…
Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer
BACKGROUND: Neoadjuvant chemotherapy (NAC) is standard for many females with breast cancer (FBC). The efficacy of NAC in male breast cancer (MaBC) is unclear. The aim of this study was to compare proportions of pathologic complete response (pCR) between MaBC and FBC by tumor subtype (TS). METHODS: M...
Autores principales: | Leone, José Pablo, Hassett, Michael J., Leone, Julieta, Tolaney, Sara M., Vallejo, Carlos T., Leone, Bernardo A., Winer, Eric P., Lin, Nancy U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826058/ https://www.ncbi.nlm.nih.gov/pubmed/36069365 http://dx.doi.org/10.1002/cncr.34448 |
Ejemplares similares
-
Factors associated with late risks of breast cancer-specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021) -
Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registry
por: Leone, José P., et al.
Publicado: (2021) -
Adjuvant systemic therapy in older women with breast cancer
por: Leone, Julieta, et al.
Publicado: (2016) -
Breast cancer brain metastases: the last frontier
por: Leone, José Pablo, et al.
Publicado: (2015) -
Male Breast Cancer: An Updated Review of Epidemiology, Clinicopathology, and Treatment
por: Zheng, Guoliang, et al.
Publicado: (2022)